Shares outstanding decreased 1.0%
Shares outstanding changed -1.0% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed -1.0% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Operating margin changed +146 basis points from the comparable as-filed period.
Operating cash flow changed -12.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net debt changed -28.1% from the comparable as-filed period.
Operating cash-flow margin changed -560 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -473 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / equity changed -446 basis points from the comparable as-filed period.
Debt / revenue changed -2625 basis points from the comparable as-filed period.
Debt / assets changed -292 basis points from the comparable as-filed period.
Revenue changed +7.3% from the comparable as-filed period.
Gross margin changed +69 basis points from the comparable as-filed period.
Inventory / revenue changed +161 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +12.8% from the comparable as-filed period.
Current assets changed +18.9% from the comparable as-filed period.
Reported total debt changed -13.3% from the comparable as-filed period.
Gross debt changed -13.3% from the comparable as-filed period.
Noncurrent long-term debt changed -13.3% from the comparable as-filed period.
Cash / debt changed +1453 basis points from the comparable as-filed period.
Operating cash flow / net income changed -22.5% from the comparable as-filed period.
Capex / revenue changed -87 basis points from the comparable as-filed period.
Stockholders' equity changed +3.6% from the comparable as-filed period.
Short-term borrowings changed from 0 to 243400000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Research & development changed +8.3% from the comparable as-filed period.
Gross profit changed +8.9% from the comparable as-filed period.
Inventory changed +11.1% from the comparable as-filed period.
Trade receivables changed +7.0% from the comparable as-filed period.
Total assets changed +3.2% from the comparable as-filed period.
SBC / revenue changed +0 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed +6.0% from the comparable as-filed period.
Selling, general & administrative changed +4.5% from the comparable as-filed period.
Current ratio changed -14.2% from the comparable as-filed period.
Stock-based compensation changed +7.6% from the comparable as-filed period.
Working capital changed +2.8% from the comparable as-filed period.
Capital expenditure changed -6.5% from the comparable as-filed period.
R&D / revenue changed +2 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -21 basis points from the comparable as-filed period.
Working capital / assets changed -4 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.